Stem cell therapy for moderate to severe COPD
Part of Lungs & breathing clinical trials.
This study tests a new treatment made from small mobile stem cells, given by inhalation, for people with moderate to severe COPD caused by smoking or pollution. It aims to see if the treatment is safe and helps improve lung function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have moderate to severe COPD caused by smoking or biomass/pollution exposure.
- Your COPD is stable, with no flare-ups or hospitalizations in the last 4 weeks and no medication changes in the last 28 days.
- You agree not to smoke, vape, or use cannabis during the study, and you are willing to follow the study schedule.
- If you are a woman who can become pregnant, you must use birth control and have a negative pregnancy test. If you are a man, you must use a condom or abstain from sex during the study.
- You have not had certain heart, kidney, or other lung diseases, and you are not currently taking oral steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new type of stem cell (SMS cells) can help people with mild or moderate COPD caused by smoking or pollution. You will receive the treatment by inhalation and be followed to see if your breathing improves.
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
This trial tests whether a special stem cell treatment can help people with moderate to severe COPD when regular medicines are not working well. The treatment may reduce breathing problems and improve quality of life.
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
This trial tests whether transplanting a patient's own lung stem cells can improve lung function in people with chronic obstructive pulmonary disease (COPD). It aims to see if this treatment is safe and helps repair damaged lung tissue.
Hear when a new Chronic Obstructive Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.